Congenital heart disease: types, pathophysiology, diagnosis, and treatment options

Abstract

Congenital heart disease (CHD) is a structural abnormality of the heart and/or great vessels and patients with CHD are at an increased risks of various morbidities throughout their lives and reduced long-term survival. Eventually, CHD may result in various complications including heart failure, arrhythmias, stroke, pneumonia, and sudden death. Unfortunately, the exact etiology and pathophysiology of some CHD remain unclear. Although the quality of life and prognosis of patients with CHD have significantly improved following technological advancement, the influence of CHD is lifelong, especially in patients with complicated CHD. Thus, the management of CHD remains a challenge due to its high prevalence. Finally, there are some disagreements on CHD among international guidelines. In this review, we provide an update of the pathophysiology, diagnosis, and treatment in most common type of CHD, including patent foramen ovale, atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent ductus arteriosus, coarctation of the aorta, transposition of the great arteries, congenitally corrected transposition of the great arteries, coronary anomalies, left and right ventricular outflow tract obstruction, tetralogy of Fallot and Ebstein anomaly. In particular, we focus on what is known and what is unknown in these areas, aiming to improve the current understanding of various types of CHD.

Keywords

congenital heart disease / diagnosis / etiology / pathophysiology / treatment

References

1	D van der Linde, EE Konings, MA Slager, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-2247.
2	Y Liu, S Chen, L Zühlke, et al. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455-463.
3	C Soares, RJ Vieira, S Costa, R Moita, M Andrade, H Guimar?es. Neurodevelopment outcomes in the first 5 years of the life of children with transposition of the great arteries surgically corrected in the neonatal period: systematic review and meta-analysis. Cardiol Young. 2023;33(12):2471-2480.
4	H Baumgartner, J De Backer, SV Babu-Narayan, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563-645.
5	G Egidy Assenza, EV Krieger, H Baumgartner, et al. AHA/ACC vs ESC guidelines for management of adults with congenital heart disease: jACC guideline comparison. J Am Coll Cardiol. 2021;78(19):1904-1918.
6	L Zhao, L Chen, T Yang, et al. Parental smoking and the risk of congenital heart defects in offspring: an updated meta-analysis of observational studies. Eur J Prev Cardiol. 2020;27(12):1284-1293.
7	S Zhang, L Wang, T Yang, et al. Parental alcohol consumption and the risk of congenital heart diseases in offspring: an updated systematic review and meta-analysis. Eur J Prev Cardiol. 2020;27(4):410-421.
8	F Han, B Yang, Y Chen, et al. Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription. Angiogenesis. 2023;26(2):217-232.
9	K Williams, J Carson, C Lo. Genetics of congenital heart disease. Biomolecules. 2019;9(12):879.
10	GP Diller, A Kempny, R Alonso-Gonzalez, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132(22):2118-2125.
11	D Massarella, R Alonso-Gonzalez. Updates in the management of congenital heart disease in adult patients. Expert Rev Cardiovasc Ther. 2022;20(9):719-732.
12	P Khairy, MJ Silka, JP Moore, et al. Sudden cardiac death in congenital heart disease. Eur Heart J. 2022;43(22):2103-2115.
13	J Somerville. Grown-up congenital heart disease-medical demands look back, look forward 2000. Thorac Cardiovasc Surg. 2001;49(1):21-26.
14	S Homma, SR Messé, T Rundek, et al. Patent foramen ovale. Nat Rev Dis Primers. 2016;2:15086.
15	PA Calvert, BS Rana, AC Kydd, LM Shapiro. Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol. 2011;8(3):148-160.
16	JJ van Vonderen, AA Roest, ML Siew, FJ Walther, SB Hooper, AB te Pas. Measuring physiological changes during the transition to life after birth. Neonatology. 2014;105(3):230-242.
17	YP Sun, S Homma. Patent foramen ovale and stroke. Circ J. 2016;80(8):1665-1673.
18	PT Hagen, DG Scholz, WD Edwards. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20.
19	CJ Rodriguez, S Homma, RL Sacco, MR Di Tullio, RR Sciacca, JP Mohr. Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients. Stroke. 2003;34(9):2097-2102.
20	J Kuramoto, A Kawamura, T Dembo, T Kimura, K Fukuda, Y Okada. Prevalence of patent foramen ovale in the Japanese population-autopsy study. Circ J. 2015;79(9):2038-2042.
21	B Meier, B Frank, A Wahl, HC Diener. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J. 2012;33(6):705-713. 713a, 713b.
22	HL Zhang, ZH Liu, Q Luo, Y Wang, ZH Zhao, CM Xiong. Paradoxical embolism: experiences from a single center. Chronic Dis Transl Med. 2017;3(2):123-128.
23	A d'Audiffret, SS Shenoy, JJ Ricotta, M Dryjski. The role of thrombolytic therapy in the management of paradoxical embolism. Cardiovasc Surg. 1998;6(3):302-306.
24	W Ren, H Huang, H Hu. Optical coherence tomography imaging evidence of thrombus inside the tunnel of patent foramen ovale. Eur Heart J. 2022;43(39):3982.
25	B Miranda, AC Fonseca, JM Ferro. Patent foramen ovale and stroke. J Neurol. 2018;265(8):1943-1949.
26	C Yan, H Li. Preliminary investigation of In situ thrombus within patent foramen ovale in patients with and without stroke. JAMA. 2021;325(20):2116-2118.
27	X Liu, C Sun, G An, L Cao, X Meng. Case report: hypereosinophilic syndrome vs. patent foramen ovale as etiopathogenetic contributors to stroke. Front Cardiovasc Med. 2023;10:1298063.
28	G Rigatelli, M Giordan, G Braggion, et al. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts. Cardiovasc Revasc Med. 2007;8(4):248-250.
29	CN Dao, JM Tobis. PFO and paradoxical embolism producing events other than stroke. Catheter Cardiovasc Interv. 2011;77(6):903-909.
30	E Doufekias, AZ Segal, JR Kizer. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol. 2008;51(11):1049-1059.
31	W Rosamond, K Flegal, G Friday, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-e171.
32	SC Cramer, JH Maki, GM Waitches, et al. Paradoxical emboli from calf and pelvic veins in cryptogenic stroke. J Neuroimaging. 2003;13(3):218-223.
33	SC Cramer, G Rordorf, JH Maki, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46-50.
34	MH Leppert, SN Poisson, JD Carroll, et al. Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke prevention. Stroke. 2018;49(6):1443-1450.
35	MK Mojadidi, MO Zaman, IY Elgendy, et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol. 2018;71(9):1035-1043.
36	AY Elgendy, JL Saver, Z Amin, et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020;77(7):878-886.
37	M Handke, A Harloff, M Olschewski, A Hetzel, A Geibel. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357(22):2262-2268.
38	I Meissner, BK Khandheria, JA Heit, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47(2):440-445.
39	MR Di Tullio, RL Sacco, RR Sciacca, Z Jin, S Homma. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49(7):797-802.
40	MM Steiner, MR Di Tullio, T Rundek, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29(5):944-948.
41	BS Wessler, DE Thaler, R Ruthazer, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014;7(1):125-131.
42	S Agarwal, NS Bajaj, DJ Kumbhani, EM Tuzcu, SR Kapadia. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv. 2012;5(7):777-789.
43	G Turc, JY Lee, E Brochet, JS Kim, JK Song, JL Mas. Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol. 2020;75(18):2312-2320.
44	G Rigatelli, S Aggio, P Cardaioli, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? JACC Cardiovasc Interv. 2009;2(7):655-662.
45	S De Castro, D Cartoni, M Fiorelli, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31(10):2407-2413.
46	SE Kasner, B Swaminathan, P Lavados, et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol. 2018;17(12):1053-1060.
47	AO Ozdemir, A Tamayo, C Munoz, B Dias, JD Spence. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1-2):121-127.
48	JD Spence. Cardioembolic stroke: everything has changed. Stroke Vasc Neurol. 2018;3(2):76-83.
49	M Fujioka, D Niino, M Ito, Y Matsuoka. Fatal paradoxical air embolism diagnosed by postmortem imaging and autopsy. J Forensic Sci. 2012;57(4):1118-1119.
50	MA Islam, K Khalighi, JE Goldstein, J Raso. Paradoxical embolism-report of a case involving four organ systems. J Emerg Med. 2000;19(1):31-34.
51	FA Hakim, EP Kransdorf, MM Abudiab, JP Sweeney. Paradoxical coronary artery embolism-a rare cause of myocardial infarction. Heart Views. 2014;15(4):124-126.
52	P Shah, A Jimenez-Ruiz, A Gibson, et al. Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale. Int J Cardiol. 2021;342:1-6.
53	FX Kleber, T Hauschild, A Schulz, A Winkelmann, L Bruch. Epidemiology of myocardial infarction caused by presumed paradoxical embolism via a patent foramen ovale. Circ J. 2017;81(10):1484-1489.
54	DR Gersony, SH Kim, M Di Tullio, A Fard, L Rabbani, S Homma. Acute myocardial infarction caused by paradoxical coronary embolization in a patient with a patent foramen ovale. J Am Soc Echocardiogr. 2001;14(12):1227-1229.
55	H Ghafoor, NK Sharma, Z Hashmath, E Ramsaran. Peripheral thrombosis causing simultaneous saddle pulmonary embolism and paradoxical ST elevation myocardial infarction resulting in cardiovascular collapse. BMJ Case Rep. 2021;14(4):e240312.
56	AR Ferreira, A Freitas, P Magno, et al. Acute coronary syndrome of paradoxical origin. Rev Port Cardiol. 2013;32(10):817-821.
57	S Barros-Gomes, A El Sabbagh, MF Eleid, SV Mankrad. Concomitant acute stroke, pulmonary and myocardial infarction due to in-transient thrombus across a patent foramen ovale. Echo Res Pract. 2018;5(4):I9-I10.
58	AM Wilson, R Ardehali, TJ Brinton, AC Yeung, R Vagelos. Successful removal of a paradoxical coronary embolus using an aspiration catheter. Nat Clin Pract Cardiovasc Med. 2006;3(11):633-636.
59	HK Meier-Ewert, SB Labib, EC Schick, DE Gossman, MS Stix, CA Williamson. Paradoxical embolism in the left main coronary artery: diagnosis by transesophageal echocardiography. Mayo Clin Proc. 2003;78(1):103-106.
60	K Liang, M Williams, C Bucciarelli-Ducci. Cardiac magnetic resonance imaging unmasks presumed embolic myocardial infarction due to patent foramen ovale case report. Eur Heart J Case Rep. 2022;6(2):ytac029.
61	P Iqbal, A Shams, M Ali, B Muthanna, T Hussain. Rare association of patent foramen ovale and atrial septal aneurysm leading to branch retinal artery occlusion in a young healthy man. Cureus. 2020;12(7):e8994.
62	L Zhu, N Xu, Y Li. Monocular central retinal artery occlusion caused by bilateral internal carotid artery hypoplasia complicated with patent foramen ovale: a case report and review of literature. Eur J Med Res. 2021;26(1):55.
63	SS Hayreh. Acute retinal arterial occlusive disorders. Prog Retin Eye Res. 2011;30(5):359-394.
64	N Shoeibi, H Poorzand, M Abrishami. Branch retinal artery occlusion in a patient with patent foramen ovale. J Ophthalmic Vis Res. 2013;8(1):58-61.
65	M Si, H Wang. Retinal artery occlusion after facial filler injection in a patient with patent foramen ovale: a case report and literature review. J Int Med Res. 2023;51(9):3000605231194514.
66	N Sabanis, G Zagkotsis, VD Krikos, E Paschou, A Tapanlis. Central retinal artery occlusion secondary to patent foramen ovale: the unexpected journey of a paradoxical embolus. Cureus. 2020;12(7):e9496.
67	S Tobalem, JS Schutz, A Chronopoulos. Central retinal artery occlusion- rethinking retinal survival time. BMC Ophthalmol. 2018;18(1):101.
68	MS Wieder, N Blace, MM Szlechter, E Shulman, J Thankenchen, JN Mbekeani. Central retinal artery occlusion associated with patent foramen ovale: a case report and literature review. Arq Bras Oftalmol. 2021;84(5):494-498.
69	HB Carey, R Boltax, KW Dickey, FO Finkelstein. Bilateral renal infarction secondary to paradoxical embolism. Am J Kidney Dis. 1999;34(4):752-755.
70	M Iwasaki, N Joki, Y Tanaka, H Hara, M Suzuki, H Hase. A suspected case of paradoxical renal embolism through the patent foramen ovale. Clin Exp Nephrol. 2011;15(1):147-150.
71	JL Lim, KK Lau, AKH Lim. Successful rescue from kidney failure with delayed catheter-directed intervention after catastrophic bilateral kidney paradoxical thromboembolism. BMJ Case Rep. 2022;15(2):e246885.
72	A Haghikia, M Hiss, KI Ringe, et al. Organ transplants do not escape paradoxical embolisms. Transpl Int. 2012;25(3):e34-37.
73	JW Greenberg, ZD Goff, AC Mooser, CM Wittgen, MR Smeds. Acute limb ischemia secondary to patent foramen ovale-mediated paradoxical embolism: a case report and systematic review of the literature. Ann Vasc Surg. 2020;66:668.e5-668.e10.
74	H Takafuji, S Hosokawa, R Ogura, Y Hiasa. Percutaneous closure of patent foramen ovale for paradoxical embolism in acute limb ischemia. Cardiovasc Interv Ther. 2019;34(3):282-284.
75	H Chughtai, J Basora, K Khan, J Matta. Massive pulmonary embolism and paradoxical migration during surgical embolectomy: role of transesophageal echocardiogram. Clin Cardiol. 2010;33(1):E20-E22.
76	O Kallel, D Charmake, I Chergui, N El Ouafi, N Ismaili. Patent foramen oval: a rare case of acute ischemia of the upper limb: a case with 2 year follow-up. Ann Med Surg (Lond). 2021;63:102188.
77	N Shahi, R Nair. Paradoxical digital ischaemia. BMJ Case Rep. 2010;2010:bcr1020092413.
78	A Amirfarhangi, S Zeraatian, M Hassanzadeh. Frequent arterial emboli in a patient with acute pulmonary thromboembolism and patent foramen ovale. Ann Vasc Surg. 2018;53:274.e7-274.e10.
79	G Santangelo, A Ielasi, F Pattarino, AT Saino, PA Scopelliti, M Tespili. Pulmonary embolism with migrating thrombus through patent foramen ovale: a case for a mixed pharmacological and percutaneous management. J Cardiol Cases. 2019;19(1):19-21.
80	Y Banana, A Rezziki, O Kallel, et al. Multiple paradoxical embolisms revealing a patent foramen ovale in a patient with deep venous thrombosis: a case report. Ann Med Surg (Lond). 2021;66:102426.
81	J W?hrle, M Kochs, V Hombach, N Merkle. Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale. JACC Cardiovasc Imaging. 2010;3(8):833-839.
82	K Onsea, MD Bogaard, FW Asselbergs, PR Stella. Simultaneous pulmonary, cerebral and coronary emboli. Int J Cardiol. 2012;157(1):e18-20.
83	SR Messé, GS Gronseth, DM Kent, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020;94(20):876-885.
84	MK Mojadidi, JS Winoker, SC Roberts, et al. Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies. Echocardiography. 2014;31(9):1036-1048.
85	AH Katsanos, T Psaltopoulou, TN Sergentanis, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: a systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625-635.
86	S Homma, RL Sacco, MR Di Tullio, RR Sciacca, JP Mohr. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105(22):2625-2631.
87	D Sagris, G Georgiopoulos, K Perlepe, et al. Antithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: systematic review and meta-analysis. Stroke. 2019;50(11):3135-3140.
88	HC Diener, A Chutinet, JD Easton, et al. Dabigatran or aspirin after embolic stroke of undetermined source in patients with patent foramen ovale: results from RE-SPECT ESUS. Stroke. 2021;52(3):1065-1068.
89	M Dubiel, L Bruch, M Liebner, et al. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure. J Interv Cardiol. 2007;20(4):275-281.
90	AJ Furlan, M Reisman, J Massaro, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991-999.
91	JD Carroll, JL Saver, DE Thaler, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092-1100.
92	B Meier, B Kalesan, HP Mattle, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083-1091.
93	P Rengifo-Moreno, IF Palacios, P Junpaparp, CF Witzke, DL Morris, A Romero-Corral. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J. 2013;34(43):3342-3352.
94	JL Mas, G Derumeaux, B Guillon, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011-1021.
95	L S?ndergaard, SE Kasner, JF Rhodes, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033-1042.
96	JL Saver, JD Carroll, DE Thaler, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022-1032.
97	HC Diener, GJ Hankey. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: jACC focus seminar. J Am Coll Cardiol. 2020;75(15):1804-1818.
98	LA Morais, L Sousa, A Fiarresga, et al. RoPE score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure. Int Heart J. 2018;59(6):1327-1332.
99	G Turc, D Calvet, P Guérin, M Sroussi, G Chatellier, JL Mas. Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study. J Am Heart Assoc. 2018;7(12):e008356.
100	JG Luermans, W Budts, JM Ten Berg, HW Plokker, MJ Suttorp, MC Post. Comparison of outcome after patent foramen ovale closure in older versus younger patients. EuroIntervention. 2011;7(2):209-215.
101	J Wintzer-Wehekind, A Alperi, C Houde, et al. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism. Rev Esp Cardiol (Engl Ed). 2020;73(3):219-224.
102	A Alperi, P Guedeney, E Horlick, et al. Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events. Circ Cardiovasc Interv. 2022;15(7):e011652.
103	AA Alsheikh-Ali, DE Thaler, DM Kent. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349-2355.
104	G Hardman, J Zacharias. Minimal-access atrial septal defect (ASD) closure. J Cardiovasc Dev Dis. 2023;10(5):206.
105	EA Bradley, AN Zaidi. Atrial septal defect. Cardiol Clin. 2020;38(3):317-324.
106	AM Dehn, S Dannesbo, A Sellmer, et al. Atrial septal defect: larger right ventricular dimensions and atrial volumes as early as in the first month after birth-a case-control study including 716 neonates. Pediatr Cardiol. 2023;44(7):1578-1586.
107	CJ Cool, W Kamarullah, R Pranata, et al. A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amid debate? Curr Probl Cardiol. 2024;49(1):102121. Pt C.
108	T Geva, JD Martins, RM Wald. Atrial septal defects. Lancet. 2014;383(9932):1921-1932.
109	V Muroke, M Jalanko, J Haukka, J Sinisalo. Cause-specific mortality of patients with atrial septal defect and up to 50 years of follow-Up. J Am Heart Assoc. 2023;12(2):e027635.
110	J Urmeneta Ulloa, V Martínez de Vega, S Hernández Jiménez, M Lobo-González, J Cabrera. 4D-flow cardiovascular magnetic resonance versus 3D transesophageal echocardiography in multifenestrated atrial septal defect. Circ Cardiovasc Imaging. 2023;16(12):e015776.
111	FE Silvestry, MS Cohen, LB Armsby, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910-958.
112	A Kheiwa, P Hari, P Madabhushi, P Varadarajan. Patent foramen ovale and atrial septal defect. Echocardiography. 2020;37(12):2172-2184.
113	Y Liu, MK Choy, S Abraham, G Tenin, GC Black, BD Keavney. Atrial septal defect (ASD) associated long non-coding RNA STX18-AS1 maintains time-course of in vitro cardiomyocyte differentiation. Genes Dis. 2023;10(4):1150-1153.
114	L Abrahamyan, C Dharma, S Alnasser, et al. Long-term outcomes after atrial septal defect transcatheter closure by age and against population controls. JACC Cardiovasc Interv. 2021;14(5):566-575.
115	A Ueda, I Adachi, KP McCarthy, W Li, SY Ho, H Uemura. Substrates of atrial arrhythmias: histological insights from patients with congenital heart disease. Int J Cardiol. 2013;168(3):2481-2486.
116	L Latson, D Briston. Atrial septal defect: transcatheter closure is not bad, but there is more to the story. JACC Cardiovasc Interv. 2021;14(5):576-577.
117	AC van Riel, MJ Schuuring, ID van Hessen, et al. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014;174(2):299-305.
118	W Budts, O Miller, SV Babu-Narayan, et al. Imaging the adult with simple shunt lesions: position paper from the EACVI and the ESC WG on ACHD. Endorsed by AEPC (Association for European Paediatric and Congenital Cardiology). Eur Heart J Cardiovasc Imaging. 2021;22(6):e58-e70.
119	X Lin, F Yang, Y Chen, et al. Echocardiography-based AI for detection and quantification of atrial septal defect. Front Cardiovasc Med. 2023;10:985657.
120	BV Devarakonda, MC Kapoor. Atrial septal occluder device embolization is avoidable. Ann Card Anaesth. 2023;26(2):122-123.
121	S Umemoto, I Sakamoto, K Abe, et al. Preoperative threshold for normalizing right ventricular volume after transcatheter closure of adult atrial septal defect. Circ J. 2020;84(8):1312-1319.
122	M Brida, M Chessa, D Celermajer, et al. Atrial septal defect in adulthood: a new paradigm for congenital heart disease. Eur Heart J. 2022;43(28):2660-2671.
123	LF Xie, Y Lin, MF Chen, GC Zhang. Complete transthoracic echocardiography for the assessment and guidance of percutaneous atrial septal defect closure in adults without balloon sizing: an observed study with a 10-year follow-up. J Cardiovasc Dev Dis. 2023;10(8):321.
124	EC Ho, M Assafin, T Sugiura, JF Granada, M Chau, A Latib. 3-dimensional intracardiac echocardiography for structural heart interventions. Front Cardiovasc Med. 2023;10:1180299.
125	T Machino-Ohtsuka, T Ishizu, Y Kawakami. Intraoperative imaging strategy unique to Japan for transcatheter closure of atrial septal defects. Circ J. 2023;87(4):525-526.
126	G Rigatelli, NT Nghia, M Zuin, L Conte, K D'Elia, A Nanjundappa. Very long-term outcomes of transcatheter secundum atrial septal defect closure using intracardiac echocardiography without balloon sizing. Clin Radiol. 2019;74(9):732.e17-732.e22.
127	F Boccalandro, E Baptista, A Muench, C Carter, RW Smalling. Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defect. Am J Cardiol. 2004;93(4):437-440.
128	F Alqahtani, A Bhirud, S Aljohani, et al. Intracardiac versus transesophageal echocardiography to guide transcatheter closure of interatrial communications: nationwide trend and comparative analysis. J Interv Cardiol. 2017;30(3):234-241.
129	TD King, SL Thompson, C Steiner, NL Mills. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235(23):2506-2509.
130	S Garre, S Gadhinglajkar, R Sreedhar, KM Krishnamoorthy, VV Pillai. Atrial septal defect occluder device embolization: experience of a tertiary care cardiac center. Ann Card Anaesth. 2023;26(2):149-154.
131	M Alkhouli, H Sievert, CS Rihal. Device embolization in structural heart interventions: incidence, outcomes, and retrieval techniques. JACC Cardiovasc Interv. 2019;12(2):113-126.
132	S Wang, W Qiao, N Dong. Residual shunt and microthrombosis associated with new-onset migraine after transcatheter atrial septal defect closure. Eur Heart J. 2023;44(43):4605.
133	B Wertman, B Azarbal, M Riedl, J Tobis. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol. 2006;47(6):1226-1227.
134	A Baroutidou, A Arvanitaki, IT Farmakis, et al. Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis. Heart. 2023;109(23):1741-1750.
135	M Suzuki, K. Matsumoto, M Suto, et al. Transcatheter atrial septal defect closure in a “nonagenarian” with intractable heart failure. Intern Med, 2020; 59(8):1059-1063.
136	UK Chowdhury, RH Anderson, NN Pandey, et al. A reappraisal of the sinus venosus defect. Eur J Cardiothorac Surg. 2022;61(6):1211-1222.
137	J Relan, SK Gupta, R Rajagopal, et al. Clarifying the anatomy of the superior sinus venosus defect. Heart. 2022;108(9):689-694.
138	AE Baruteau, S Hascoet, S Malekzadeh-Milani, et al. Transcatheter closure of superior sinus venosus defects. JACC Cardiovasc Interv. 2023;16(21):2587-2599.
139	K Sivakumar, S Qureshi, S Pavithran, S Vaidyanathan, M Rajendran. Simple diagnostic tools may guide transcatheter closure of superior sinus venosus defects without advanced imaging techniques. Circ Cardiovasc Interv. 2020;13(12):e009833.
140	E Rosenthal, SA Qureshi, M Jones, et al. Correction of sinus venosus atrial septal defects with the 10 zig covered Cheatham-platinum stent-an international registry. Catheter Cardiovasc Interv. 2021;98(1):128-136.
141	JH Hansen, P Duong, SGM Jivanji, et al. Transcatheter correction of superior sinus venosus atrial septal defects as an alternative to surgical treatment. J Am Coll Cardiol. 2020;75(11):1266-1278.
142	Y Hejazi, ZM Hijazi, HA Saloos, H Ibrahim, GS Mann, Y Boudjemline. Novel technique for transcatheter closure of sinus venosus atrial septal defect: the temporary suture-holding technique. Catheter Cardiovasc Interv. 2022;100(6):1068-1077.
143	Z Zhou, Y Gu, H Zheng, et al. Transcatheter closure of inferior sinus venosus defect using a patent ductus arteriosus occluder following simulation with a 3D-printed model. J Thorac Dis. 2022;14(7):2461-2471.
144	G Santoro, G Gaio, MG Russo. Transcatheter treatment of unroofed coronary sinus. Catheter Cardiovasc Interv. 2013;81(5):849-852.
145	JK Wang, SJ Chen, JY Hsu, et al. Midterm follow-up results of transcatheter treatment in patients with unroofed coronary sinus. Catheter Cardiovasc Interv. 2014;83(2):243-249.
146	Z Zhou, Y Gu, H Zheng. Transcatheter closure of unroofed coronary sinus syndrome: a short-term result. Eur Heart J. 2022;43(20):1996.
147	S Shahanavaz, DS Winlaw, AR Opotowsky. What is blocking transcatheter ventricular septal defect closure? J Am Heart Assoc. 2022;11(7):e024963.
148	S He, F Zhao, X Liu, et al. Prevalence of congenital heart disease among school children in Qinghai Province. BMC Pediatr. 2022;22(1):331.
149	L Lopez, L Houyel, SD Colan, et al. Classification of ventricular septal defects for the eleventh iteration of the international classification of diseases-striving for consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann Thorac Surg. 2018;106(5):1578-1589.
150	TA Chaudhry, M Younas, A Baig. Ventricular septal defect and associated complications. J Pak Med Assoc. 2011;61(10):1001-1004.
151	M Mostefa-Kara, D Bonnet, E Belli, E Fadel, L Houyel. Anatomy of the ventricular septal defect in outflow tract defects: similarities and differences. J Thorac Cardiovasc Surg. 2015;149(3):682-688. .e681.
152	A Adan, L Eleyan, M Zaidi, A Ashry, R Dhannapuneni, A Harky. Ventricular septal defect: diagnosis and treatments in the neonates: a systematic review. Cardiol Young. 2021;31(5):756-761.
153	S Nayak, A Patel, L Haddad, M Kanakriyeh, P Varadarajan. Echocardiographic evaluation of ventricular septal defects. Echocardiography. 2020;37(12):2185-2193.
154	ES Rothstein, RT Palac, DJ O'Rourke, P Venkataraman, AS Gemignani, SE Friedman. Evaluation of echocardiographic derived parameters for right ventricular size and function using cardiac magnetic resonance imaging. Echocardiography. 2021;38(8):1336-1344.
155	BH Morray. Ventricular septal defect closure devices, techniques, and outcomes. Interv Cardiol Clin. 2019;8(1):1-10.
156	U Krause. Age Matters: atrial arrhythmias in adult patients with atrioventricular septal defect. JACC Clin Electrophysiol. 2022;8(3):341-342.
157	E Buratto, T Hu, A Lui, et al. Early repair of complete atrioventricular septal defect has better survival than staged repair after pulmonary artery banding: a propensity score-matched study. J Thorac Cardiovasc Surg. 2021;161(5):1594-1601.
158	K Schumacher, M Marin Cuartas, S Meier, et al. Long-term results following atrioventricular septal defect repair. J Cardiothorac Surg. 2023;18(1):250.
159	LS Fong, K Betts, D Bell, et al. Complete atrioventricular septal defect repair in Australia: results over 25 years. J Thorac Cardiovasc Surg. 2020;159(3):1014-1025.
160	JJ Ramgren, S Nozohoor, I Zindovic, R Gustafsson, N Hakacova, J Sj?gren. Long-term outcome after early repair of complete atrioventricular septal defect in young infants. J Thorac Cardiovasc Surg. 2021;161(6):2145-2153.
161	E Jacquemart, F Bessière, N Combes, et al. Incidence, risk factors, and outcomes of atrial arrhythmias in adult patients with atrioventricular septal defect. JACC Clin Electrophysiol. 2022;8(3):331-340.
162	S Parkerson, R Philip, A Talati, S Sathanandam. Management of patent ductus arteriosus in premature infants in 2020. Front Pediatr. 2020;8:590578.
163	H Suciu, MM Harpa, L Moraru, AD Raicea, VC Raicea. Surgical treatment for patent ductus arteriosus in adult patients: a single center experience. Rom J Morphol Embryol. 2022;63(4):633-638.
164	B Deselina, ST Putra, R Suradi. Prevalence of patent ductus arteriosus in premature infants at the neonatal ward, Cipto Mangunkusumo Hospital, Jakarta. Paediatr Indones. 2016;44(6):223.
165	LF Eilers, WB Kyle, HD Allen, AM Qureshi. Patent ductus arteriosus. Pediatr Rev. 2021;42(11):632-634.
166	N Bussmann, A Smith, CR Breatnach, et al. Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort. J Perinatol. 2021;41(5):1134-1141.
167	S Mitra, WP de Boode, DE Weisz, PS Shah. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of cochrane systematic reviews. Cochrane Database Syst Rev. 2023;4(4):CD013588.
168	J Xu, L Wang, Y Shen, L Geng, F Chen. Transcatheter closure for patent ductus arteriosus in patients with Eisenmenger syndrome: to do or not? BMC Cardiovasc Disord. 2020;20(1):505.
169	Y Zhang, W Zhang, G Yao, et al. Qualitative and quantitative diagnosis of patent ductus arteriosus by multiplane transesophageal echocardiography. Chin J Ultra Med. 1995(11):425-428.
170	Guidelines for the management of congenital heart diseases in childhood and adolescence. Cardiol Young. 2017;27(S3):S1-S105.
171	BH Morray, SK Sathanandam, T Forbes, et al. 3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo? Occluder for transcatheter patent ductus arteriosus closure in children ≥700 grams. J Perinatol. 2023;43(10):1238-1244.
172	C Tabb, S Aggarwal, M Bajaj, G Natarajan. Comparative effectiveness of surgical ligation and catheter closure of patent ductus arteriosus in preterm infants. Pediatr Cardiol. 2023. Online ahead of print.
173	S Mitra, ID Florez, ME Tamayo, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA. 2018;319(12):1221-1238.
174	CD Jackson, AC Capino, LH Stuart, JL Wagner. Evaluation of the closure of patent ductus arteriosus with ibuprofen compared to indomethacin. J Pediatr Pharmacol Ther. 2023;28(7):618-627.
175	S Gupta, NV Subhedar, JL Bell, et al. Trial of selective early treatment of patent ductus arteriosus with ibuprofen. N Engl J Med. 2024;390(4):314-325.
176	M Honnorat, T Perouse-De-Montclos, M Bakloul, C Walton, M Butin, P Vo Van. Transcatheter closure of patent ductus arteriosus in preterm infants: results from a single-center cohort. Front Pediatr. 2023;11:1292623.
177	OM Barry, TM Gudausky, DT Balzer, et al. Safety and short-term outcomes for infants < 2.5 kg undergoing PDA device closure: a C3PO registry study. Pediatr Cardiol. 2023;44(6):1406-1413.
178	CE Tomasulo, MJ Gillespie, D Munson, et al. Incidence and fate of device-related left pulmonary artery stenosis and aortic coarctation in small infants undergoing transcatheter patent ductus arteriosus closure. Catheter Cardiovasc Interv. 2020;96(4):889-897.
179	CDS Melchior, GR Neves, BL de Oliveira, et al. Percutaneous closure of patent ductus arteriosus versus surgical treatment in low-birth-weight preterms: a systematic review and meta-analysis. Cardiol Young. 2024;34(4):705-712.
180	YY Kim, L Andrade, SC Cook. Aortic coarctation. Cardiol Clin. 2020;38(3):337-351.
181	KB Salciccioli, JP Zachariah. Coarctation of the aorta: modern paradigms across the lifespan. Hypertension. 2023;80(10):1970-1979.
182	E Chou, JP Pirruccello, PT Ellinor, ME Lindsay. Genetics and mechanisms of thoracic aortic disease. Nat Rev Cardiol. 2023;20(3):168-180.
183	T Gong, F Zhang, L Feng, et al. Diagnosis and surgical outcomes of coarctation of the aorta in pediatric patients: a retrospective study. Front Cardiovasc Med. 2023;10:1078038.
184	LM Beauchesne, HM Connolly, NM Ammash, CA Warnes. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38(6):1728-1733.
185	RM Debiec, SE Hamby, PD Jones, et al. Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions. Heart. 2022;108(14):1114-1120.
186	L Gronningsaeter, E Langesaeter, IK S?rbye, et al. High prevalence of pre-eclampsia in women with coarctation of the aorta. Eur Heart J Open. 2023;3(4):oead072.
187	KP Ramlakhan, I Malhamé, A Marelli, et al. Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry. Eur Heart J. 2022;43(38):3749-3761.
188	KK Stout, CJ Daniels, JA Aboulhosn, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(14):e698-e800.
189	I Leo, J Sabatino, M Avesani, et al. Non-invasive imaging assessment in patients with aortic coarctation: a contemporary review. J Clin Med. 2023;13(1):28.
190	K Lannering, M Bartos, M Mellander. Late diagnosis of coarctation despite prenatal ultrasound and postnatal pulse oximetry. Pediatrics. 2015;136(2):e406-e412.
191	RK Chang, M Gurvitz, S Rodriguez. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med. 2008;162(10):969-974.
192	D Ryd, K Fricke, M Bhat, H Arheden, P Liuba, E Hedstr?m. Utility of fetal cardiovascular magnetic resonance for prenatal diagnosis of complex congenital heart defects. JAMA Netw Open. 2021;4(3):e213538.
193	KC Harris, W Du, CG Cowley, TJ Forbes, DW Kim. A prospective observational multicenter study of balloon angioplasty for the treatment of native and recurrent coarctation of the aorta. Catheter Cardiovasc Interv. 2014;83(7):1116-1123.
194	A Colle, SK Enciso, L Brunee, et al. Aortic coarctation stenting in adolescents and adults: a single-center experience. Vasc Endovascular Surg. 2023;57(8):863-868.
195	P Eriksson, J Pihkala, AS Jensen, et al. Transcatheter intervention for coarctation of the aorta: a nordic population-based registry with long-term follow-up. JACC Cardiovasc Interv. 2023;16(4):444-453.
196	SS Pickard, K Gauvreau, M Gurvitz, et al. A national population-based study of adults with coronary artery disease and coarctation of the aorta. Am J Cardiol. 2018;122(12):2120-2124.
197	Improved national prevalence estimates for 18 selected major birth defects-United States, 1999–2001. MMWR Morb Mortal Wkly Rep. 2006;54(51):1301-1305.
198	JM Lim, P Porayette, D Marini, et al. Associations between age at arterial switch operation, brain growth, and development in infants with transposition of the great arteries. Circulation. 2019;139(24):2728-2738.
199	CA Warnes. Transposition of the great arteries. Circulation. 2006;114(24):2699-2709.
200	JW Roos-Hesselink, FJ Meijboom, SE Spitaels, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22–29 years). Eur Heart J. 2004;25(14):1264-1270.
201	F Bevilacqua, G Pasqualin, P Ferrero, et al. Overview of long-term outcome in adults with systemic right ventricle and transposition of the great arteries: a review. Diagnostics (Basel). 2023;13(13):2205.
202	MM Ansari Ramandi, H Yarmohammadi, B Gareb, AA Voors, JP van Melle. Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: a systematic review and meta-analysis. Int J Cardiol. 2023;389:131159.
203	MJ Lewis, A Van Dissel, J Kochav, et al. Cardiac MRI predictors of adverse outcomes in adults with a systemic right ventricle. ESC Heart Fail. 2022;9(2):834-841.
204	A Sengupta, CK Carreon, K Gauvreau, et al. Growth of the neo-aortic root and prognosis of transposition of the great arteries. J Am Coll Cardiol. 2024;83(4):516-527.
205	MS Hicks, RS Sauve, CM Robertson, et al. Early childhood language outcomes after arterial switch operation: a prospective cohort study. Springerplus. 2016;5(1):1681.
206	J Cohen, B Arya, R Caplan, et al. Congenitally corrected transposition of the great arteries: fetal diagnosis, associations, and postnatal outcome: a fetal heart society research collaborative study. J Am Heart Assoc. 2023;12(11):e029706.
207	J Auer, C Pujol, SJ Maurer, N Nagdyman, P Ewert, O Tutarel. Congenitally corrected transposition of the great arteries in adults-a contemporary single center experience. J Cardiovasc Dev Dis. 2021;8(9):113.
208	AC van Dissel, AR Opotowsky, LJ Burchill, et al. End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study. Eur Heart J. 2023;44(34):3278-3291.
209	TT Doan, S Sachdeva, C Bonilla-Ramirez, et al. Ischemia in anomalous aortic origin of a right coronary artery: large pediatric cohort medium-term outcomes. Circ Cardiovasc Interv. 2023;16(4):e012631.
210	S Molossi, H Agrawal, CM Mery, et al. Outcomes in anomalous aortic origin of a coronary artery following a prospective standardized approach. Circ Cardiovasc Interv. 2020;13(2):e008445.
211	KK Stout, CJ Daniels, JA Aboulhosn, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(14):e637-e697.
212	J Adjedj, F Hyafil, X Halna du Fretay, et al. Physiological evaluation of anomalous aortic origin of a coronary artery using computed tomography- derived fractional flow reserve. J Am Heart Assoc. 2021;10(7):e018593.
213	F Demir, T Akba?, S Erdem, et al. Anomalous origin of coronary arteries from the pulmonary artery: a single-center experience. Turk Gogus Kalp Damar Cerrahisi Derg. 2023;31(1):19-28.
214	HW Goo. Imaging findings of coronary artery fistula in children: a pictorial review. Korean J Radiol. 2021;22(12):2062-2072.
215	M Al-Hijji, A El Sabbagh, S El Hajj, et al. Coronary artery fistulas: indications, techniques, outcomes, and complications of transcatheter fistula closure. JACC Cardiovasc Interv. 2021;14(13):1393-1406.
216	A Pisesky, LE Nield, J Rosenthal, ET Jaeggi, LK Hornberger. Comparison of pre- and postnatally diagnosed coronary artery fistulae: echocardiographic features and clinical outcomes. J Am Soc Echocardiogr. 2022;35(12):1322-1335.
217	W Sumaya, D Horne, R Chen, O Elkhateeb. Novel telescope anchoring technique for closure of gigantic coronary fistulae using 3-dimensional printing for planning. JACC Cardiovasc Interv. 2022;15(8):896-897.
218	J Yasuhara, K Schultz, AM Bigelow, V Garg. Congenital aortic valve stenosis: from pathophysiology to molecular genetics and the need for novel therapeutics. Front Cardiovasc Med. 2023;10:1142707.
219	GK Singh. Congenital aortic valve stenosis. Children (Basel). 2019;6(5):69.
220	K M?kikallio, DB McElhinney, JC Levine, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation. 2006;113(11):1401-1405.
221	CK Olofsson, K Hanseus, JJ Ramgren, MJ Synnergren, J Sunneg?rdh. Outcomes in neonatal critical and non-critical aortic stenosis: a retrospective cohort study. Arch Dis Child. 2023;108(5):398-404.
222	AR Hastreiter, M Oshima, RA Miller, M Lev, MH Paul. Congenital aortic stenosis syndrome in infancy. Circulation. 1963;28:1084-1095.
223	AC Egbe, HM Connolly, JT Poterucha, CA Warnes. Bicuspid and unicuspid aortic valve: fate of moderate/severe mixed aortic valve disease. Congenit Heart Dis. 2017;12(1):24-31.
224	B Mendel, K Kohar, S Amirah, et al. The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: a systematic review and meta-analysis. Int J Cardiol. 2023;382:106-111.
225	Z Urbán, J Zhang, EC Davis, et al. Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene. Hum Genet. 2001;109(5):512-520.
226	A Guariento, VL Vida. Supravalvular aortic stenosis: the long-term story of a mischievous disease. Eur J Cardiothorac Surg. 2024;65(1):ezad429.
227	B Peng, Q Wang. Avoidance of malignant arrhythmia caused by displacement of the right coronary artery ostium in surgical correction of supravalvular aortic stenosis. J Int Med Res. 2019;47(11):5702-5710.
228	R Roemers, J Kluin, F de Heer, et al. Surgical Correction of supravalvar aortic stenosis: 52 years' experience. World J Pediatr Congenit Heart Surg. 2018;9(2):131-138.
229	F Meccanici, ML Notenboom, J Meijssen, et al. Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study. Eur J Cardiothorac Surg. 2024;65(1):ezad360.
230	K Babaoglu, AG Eroglu, F Oztun?, et al. Echocardiographic follow-up of children with isolated discrete subaortic stenosis. Pediatr Cardiol. 2006;27(6):699-706.
231	CJ McMahon, K Gauvreau, JC Edwards, T Geva. Risk factors for aortic valve dysfunction in children with discrete subvalvar aortic stenosis. Am J Cardiol. 2004;94(4):459-464.
232	AE Crofton, SL Kovacs, JA Stern. Subvalvular aortic stenosis: learning from human and canine clinical research. Cardiol Res. 2023;14(5):319-333.
233	CV Rohlicek, SF del Pino, M Hosking, J Miro, JM C?té, J Finley. Natural history and surgical outcomes for isolated discrete subaortic stenosis in children. Heart. 1999;82(6):708-713.
234	B Santens, R De Bosscher, W Budts, J Bogaert. Exercise cardiac magnetic resonance imaging to assess dynamic right ventricular outflow tract obstruction in congenital heart disease: a case report. Eur Heart J Case Rep. 2020;5(1):ytaa431.
235	M Rohit, P Rajan. Approach to cyanotic congenital heart disease in children. Indian J Pediatr. 2020;87(5):372-380.
236	EV Krieger, AM Valente. Tetralogy of Fallot. Cardiol Clin. 2020;38(3):365-377.
237	M Abumehdi, D Sasikumar, M Chaudhari, et al. Stenting of the right ventricular outflow tract as an initial intervention in Tetralogy of Fallot with pulmonary stenosis and major aortopulmonary collateral arteries. Cardiol Young. 2021;31(3):452-459.
238	AK Chau. Transcatheter pulmonary valve replacement in congenital heart diseases. Pediatr Investig. 2022;6(4):280-290.
239	DB McElhinney, Y Zhang, DS Levi, et al. Reintervention and survival after transcatheter pulmonary valve replacement. J Am Coll Cardiol. 2022;79(1):18-32.
240	Attenhofer Jost CH, HM Connolly, JA Dearani, WD Edwards, GK Danielson. Ebstein's anomaly. Circulation. 2007;115(2):277-285.
241	KA Holst, HM Connolly, JA Dearani. Ebstein's anomaly. Methodist Debakey Cardiovasc J. 2019;15(2):138-144.
242	V Raju, JA Dearani, HM Burkhart, et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann Thorac Surg. 2014;98(1):167-173.
243	Y Zhang, J Wang, J Zhao, et al. Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China. Lancet Child Adolesc Health. 2023;7(7):479-489.
244	Q Xu, H Fa, P Yang, Q Wang, Q Xing. Progress of biodegradable polymer application in cardiac occluders. J Biomed Mater Res B Appl Biomater. 2024;112(1):e35351.
245	L Zhao, L Chen, T Yang, et al. Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol. 2020;35(7):631-642.
246	KW Giang, Z Mandalenakis, M Fedchenko, et al. Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden. Eur J Prev Cardiol. 2023;30(2):169-176.
247	PKH Tam, KKY Wong, A Atala, et al. Regenerative medicine: postnatal approaches. Lancet Child Adolesc Health. 2022;6(9):654-666.